These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2084728)

  • 21. Menstrual cycle and ovarian hormone effects on plasma and platelet monoamine oxidase (MAO) and plasma dopamine-beta-hydroxylase (DBH) activities in the rhesus monkey.
    Redmond DE; Murphy DL; Baulu J; Ziegler MG; Lake CR
    Psychosom Med; 1975; 37(5):417-28. PubMed ID: 808811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in lithium-treated bipolar patients.
    Sofuoğlu S; Doğan P; Köse K; Eşel E; Baştũrk M; Oğuz H; Gönül AS
    Psychiatry Res; 1995 Nov; 59(1-2):165-70. PubMed ID: 8771233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Platelet monoamine oxidase and sex hormones in a population of depressed patients].
    Poirier MF; Lôo H; Lefur G; Mitrani N
    Encephale; 1985; 11(3):125-9. PubMed ID: 4029076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
    Fähndrich E
    Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet monoamine oxidase and serum dopamine-beta-hydroxylase activity in chronic alcoholics.
    Sullivan JL; Stanfield CN; Schanberg S; Cavenar J
    Arch Gen Psychiatry; 1978 Oct; 35(10):1209-12. PubMed ID: 697539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet monoamine oxidase and serum dopamine-beta-hydroxylase activities in psychotic patients.
    Zizolfi S; Famiglietti LA; Del Vecchio M; Kemali D
    Acta Neurol (Napoli); 1979 Apr; 1(2):142-9. PubMed ID: 474224
    [No Abstract]   [Full Text] [Related]  

  • 28. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
    Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
    Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma DBH, platelet MAO and proteins of red blood cell membranes in individuals with variants of the normal EEG.
    Propping P; Friedl W; Nebel B; Feige A
    Neuropsychobiology; 1979; 5(6):309-16. PubMed ID: 503304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet monoamine oxidase activity and behavioral response to pharmacotherapy in psychiatric patients.
    Rosen AJ; Wirtshafter D; Pandey GN; Davis JM
    Psychiatry Res; 1982 Feb; 6(1):49-59. PubMed ID: 6120529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma dopamine-beta-hydroxylase in depressed patients.
    Matuzas W; Meltzer HY; Uhlenhuth EH; Glass RM; Tong C
    Biol Psychiatry; 1982 Dec; 17(12):1415-24. PubMed ID: 7159639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in patients with multiple sclerosis.
    Markianos M; Sfagos C; Bistolaki E
    Acta Neurol Scand; 1991 Dec; 84(6):531-3. PubMed ID: 1792858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [EEG sleep patterns and biogenic amine metabolizing enzymes in patients with endogenous depression].
    Nowicki Z; Gałuszko P; Landowski J
    Psychiatr Pol; 1991; 25(3-4):1-3. PubMed ID: 1821968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients.
    Bannink M; Kruit WH; Van Gool AR; Mulder PG; Sleijfer S; Eggermont AM; Stoter G; Fekkes D
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):109-14. PubMed ID: 15610952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DBH, MHPG, and MAO in children with depressive, anxiety, and conduct disorders: relationship to diagnosis and symptom ratings.
    Pliszka SR; Rogeness GA; Medrano MA
    Psychiatry Res; 1988 Apr; 24(1):35-44. PubMed ID: 3393617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in non-abstinent chronic alcoholics. Relation to clinical parameters.
    Lykouras E; Moussas G; Markianos M
    Drug Alcohol Depend; 1987 Jul; 19(4):363-8. PubMed ID: 3608795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme studies in tardive dyskinesia. I. One-year biochemical follow-up.
    Wagner RL; Jeste DV; Phelps BH; Wyatt RD
    J Clin Psychopharmacol; 1982 Oct; 2(5):312-4. PubMed ID: 7130432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Psychophysiological characteristics and metabolic indices of neurotransmitter metabolism in patients ill with endogenous depression].
    Wójcik M; Bidziński A; Slósarska M; Puzyński S
    Psychiatr Pol; 1992; 26(3-4):185-95. PubMed ID: 1301598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
    Georgotas A; Mann J; Friedman E
    Biol Psychiatry; 1981 Oct; 16(10):997-1001. PubMed ID: 7306621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.